RBF Capital LLC Lowers Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

RBF Capital LLC reduced its stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 420,074 shares of the company’s stock after selling 101,245 shares during the period. RBF Capital LLC’s holdings in KORU Medical Systems were worth $1,617,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of KRMD. JPMorgan Chase & Co. increased its position in KORU Medical Systems by 2,770.7% during the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company’s stock worth $68,000 after purchasing an additional 17,095 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of KORU Medical Systems during the 4th quarter worth $73,000. Y Intercept Hong Kong Ltd purchased a new position in shares of KORU Medical Systems in the 4th quarter worth $104,000. Raymond James Financial Inc. acquired a new position in KORU Medical Systems in the fourth quarter valued at $118,000. Finally, HighTower Advisors LLC grew its position in KORU Medical Systems by 13.0% during the fourth quarter. HighTower Advisors LLC now owns 43,400 shares of the company’s stock valued at $167,000 after acquiring an additional 5,000 shares during the period. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Trading Up 8.0 %

NASDAQ:KRMD opened at $2.42 on Wednesday. KORU Medical Systems, Inc. has a one year low of $1.86 and a one year high of $5.05. The business’s 50-day simple moving average is $2.90 and its 200 day simple moving average is $3.37. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. The stock has a market cap of $111.22 million, a price-to-earnings ratio of -9.68 and a beta of 0.87.

Analysts Set New Price Targets

A number of analysts have recently issued reports on KRMD shares. Craig Hallum boosted their target price on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, January 17th. Lake Street Capital boosted their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. B. Riley raised shares of KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $4.50 price target on shares of KORU Medical Systems in a report on Friday, February 14th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, KORU Medical Systems presently has an average rating of “Buy” and a consensus price target of $4.70.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.